The Warburg effect drives dedifferentiation through epigenetic reprogramming

References

1. 1.↵
   2. Warburg O,
   3. Posener K,
   4. Negelein E.

   On the metabolism of carcinoma cells. Biochem Z. 1924; 152: 309–44.

   OpenUrlWeb of Science
2. 2.↵
   2. Warburg O,
   3. Wind F,
   4. Negelein E.

   The metabolism of tumors in the body. J Gen Physiol. 1927; 8: 519–30.

   OpenUrlFREE Full Text
3. 3.↵
   2. Liberti MV,
   3. Locasale JW.

   The warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016; 41: 211–8.

   OpenUrlCrossRefPubMed
4. 4.↵
   2. Vander Heiden MG,
   3. Cantley LC,
   4. Thompson CB.

   Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009; 324: 1029–33.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   2. House SW,
   3. Warburg O,
   4. Burk D,
   5. Schade AL.

   On respiratory impairment in cancer cells. Science. 1956; 124: 267–72.

   OpenUrlFREE Full Text
6. 6.↵
   2. Warburg O.

   On the origin of cancer cells. Science. 1956; 123: 309–14.

   OpenUrlFREE Full Text
7. 7.↵
   2. Kinnaird A,
   3. Zhao S,
   4. Wellen KE,
   5. Michelakis ED.

   Metabolic control of epigenetics in cancer. Nat Rev Cancer. 2016; 16: 694–707.

   OpenUrl
8. 8.↵
   2. Reznik E,
   3. Miller ML,
   4. Senbabaoglu Y,
   5. Riaz N,
   6. Sarungbam J,
   7. Tickoo SK, et al.

   Mitochondrial DNA copy number variation across human cancers. Elife. 2016; 5: e10769.
9. 9.
   2. Kopinski PK,
   3. Singh LN,
   4. Zhang S,
   5. Lott MT,
   6. Wallace DC.

   Mitochondrial DNA variation and cancer. Nat Rev Cancer. 2021; 21: 431–45.

   OpenUrl
10. 10.↵
    2. Kong M,
    3. Guo L,
    4. Xu W,
    5. He C,
    6. Jia X,
    7. Zhao Z, et al.

    Aging-associated accumulation of mitochondrial DNA mutations in tumor origin. Life Med. 2022; 1: 149–67.

    OpenUrl
11. 11.↵
    2. Qian L,
    3. Zhang F,
    4. Yin M,
    5. Lei Q.

    Cancer metabolism and dietary interventions. Cancer Biol Med. 2021; 19: 163–74.

    OpenUrl
12. 12.↵
    2. Lu C,
    3. Thompson CB.

    Metabolic regulation of epigenetics. Cell Metab. 2012; 16: 9–17.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    2. Bartman CR,
    3. Weilandt DR,
    4. Shen Y,
    5. Lee WD,
    6. Han Y,
    7. TeSlaa T, et al.

    Slow TCA flux and ATP production in primary solid tumours but not metastases. Nature. 2023; 614: 349–57.

    OpenUrl
14. 14.↵
    2. Pavlova NN,
    3. Zhu J,
    4. Thompson CB.

    The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022; 34: 355–77.

    OpenUrlCrossRefPubMed
15. 15.↵
    2. Zhao YZ,
    3. Wang AX,
    4. Zou YJ,
    5. Su N,
    6. Loscalzo J,
    7. Yang Y.

    In vivo monitoring of cellular energy metabolism using SoNar, a highly responsive sensor for NAD(+)/NADH redox state. Nat Protoc. 2016; 11: 1345–59.

    OpenUrlCrossRefPubMed
16. 16.↵
    2. Pavlova NN,
    3. Thompson CB.

    The emerging hallmarks of cancer metabolism. Cell Metab. 2016; 23: 27–47.

    OpenUrlCrossRefPubMed
17. 17.↵
    2. Li AM,
    3. Ye J.

    Deciphering the Warburg effect: metabolic reprogramming, epigenetic remodeling, and cell dedifferentiation. Ann Rev Cancer Biol. 2024; 8.
18. 18.↵
    2. Hanahan D.

    Hallmarks of cancer: new dimensions. Cancer Discov. 2022; 12: 31–46.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    2. Ye D,
    3. Guan KL,
    4. Xiong Y.

    Metabolism, activity, and targeting of D- and L-2-Hydroxyglutarates. Trends Cancer. 2018; 4: 151–65.

    OpenUrl
20. 20.↵
    2. Li AM,
    3. He B,
    4. Karagiannis D,
    5. Li Y,
    6. Jiang H,
    7. Srinivasan P, et al.

    Serine starvation silences estrogen receptor signaling through histone hypoacetylation. Proc Natl Acad Sci USA. 2023; 120: e2302489120.
21. 21.↵
    2. Li Y,
    3. Gruber JJ,
    4. Litzenburger UM,
    5. Zhou Y,
    6. Miao YR,
    7. LaGory EL, et al.

    Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia. Cell Death Dis. 2020; 11: 102.

    OpenUrlCrossRef
22. 22.↵
    2. Li AM,
    3. Ye JB.

    The PHGDH enigma: do cancer cells only need serine or also a redox modulator? Cancer Lett. 2020; 476: 97–105.

    OpenUrlCrossRef
23. 23.↵
    2. Ye J,
    3. Mancuso A,
    4. Tong X,
    5. Ward PS,
    6. Fan J,
    7. Rabinowitz JD, et al.

    Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A. 2012; 109: 6904–9.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    2. Diehl FF,
    3. Lewis CA,
    4. Fiske BP,
    5. Vander Heiden MG.

    Cellular redox state constrains serine synthesis and nucleotide production to impact cell proliferation. Nat Metab. 2019; 1: 861–7.

    OpenUrl
25. 25.↵
    2. Jiang H,
    3. Li AM,
    4. Ye J.

    The magic bullet: niclosamide. Front Oncol. 2022; 12: 1004978.
26. 26.↵
    2. Jiang H,
    3. Greathouse RL,
    4. Tiche SJ,
    5. Zhao M,
    6. He B,
    7. Li Y, et al.

    Mitochondrial uncoupling induces epigenome remodeling and promotes differentiation in neuroblastoma. Cancer Res. 2023; 83: 181–94.

    OpenUrl
27. 27.↵
    2. Jiang H,
    3. He CJ,
    4. Li AM,
    5. He B,
    6. Li Y,
    7. Zhou MN, et al.

    Mitochondrial uncoupling inhibits reductive carboxylation in cancer cells. Mol Cancer Res. 2023; 21: 1010–6.

    OpenUrl